Skip to main content
Livermore
Livermore
ZHEN

Prime Medicine, Inc.

PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001894562

No open-market purchases or sales by Prime Medicine, Inc. insiders were filed in the last 90 days; 187 institutions reported holding it in 13F filings for Q2 2026, worth $393.5M in total; ARK Invest is the only superinvestor holding it.

Superinvestors holding PRME, Q2 2026

1 superinvestor reports holding Prime Medicine, Inc. on Form 13F, worth $30.8M in total. Weight is Prime Medicine, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding PRME in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
ARK InvestCathie Wood0.2%8,348,746$30.8MAdded+33.6%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of PRME each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+33.6%)

  2. Q1 2026

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+16.4%)

  3. Q4 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−2.0%)

  4. Q3 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+135.8%)

  5. Q2 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−25.0%)

  6. Q1 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−39.9%)

  7. Q4 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−9.0%)

  8. Q3 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−7.6%)

  9. Q2 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+2.2%)

  10. Q1 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+91.0%)

  11. Q4 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+19.7%)

  12. Q3 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+7.1%)

  13. Q2 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+27.4%)

  14. Q1 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+17.2%)

  15. Q4 2022

    1 superinvestor holding at quarter end

    New
    ARK Invest